EMElena Mantilla-Rodríguez

Elena Mantilla-Rodríguez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Mantilla-Rodríguez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel Asunción-Alvarez

    Grupo de Investigación en Estudios de Compuestos Naturales y Sintéticos con Actividad a Nivel Sistema Nervioso Central y Musculo Liso, Laboratorio de Farmacología, Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Trujillo 13011, Peru

    5 shared publications
  • Ivan M. Quispe Diaz

    Grupo de Investigación en Estudios de Compuestos Naturales y Sintéticos con Actividad a Nivel Sistema Nervioso Central y Musculo Liso, Laboratorio de Farmacología, Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Trujillo 13011, Peru

    5 shared publications
  • Julio Benites

    Programa de Doctorado en Química Medicinal, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, Iquique 1110939, Chile

    5 shared publications
  • Roberto Osmundo Ybañez Julca

    Grupo de Investigación en Estudios de Compuestos Naturales y Sintéticos con Actividad a Nivel Sistema Nervioso Central y Musculo Liso, Laboratorio de Farmacología, Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Trujillo 13011, Peru

    5 shared publications
  • Edison Vásquez-Corales

    Vicerrectorado de Investigación y Postgrado, Universidad Católica Los Ángeles de Chimbote, Chimbote 02801, Peru

    4 shared publications
  • Wilfredo O. Gutiérrez-Alvarado

    Facultad de Farmacia y Bioquímica, Universidad Nacional de la Amazonía Peruana, Iquitos 16001, Peru

    4 shared publications

Latest Publications

  • Open Access

    Solvent-Free Mechanochemical Synthesis, Antispasmodic Activity, and Integrated In Silico Mechanistic Analysis of a Dapsone-Derived Phenylaminojuglone

    by Ricardo E. Zavaleta-Miñano, Elena Mantilla-Rodríguez, Roberto O. Ybañez-Julca, Daniel Asunción-Alvarez, Cinthya Enriquez-Lara, Justo Huertas-Córdova, Iván M. Quispe-Díaz, Rafael Jara-Aguilar, Edison Vásquez-Corales, Wilfredo O. Gutiérrez-Alvarado, et al.

    The structural hybridization of bioactive quinones is a promising strategy for generating pharmacologically active compounds through sustainable synthetic approaches. This study aimed to synthesize and evaluate a dapsone-derived phenylaminojuglone as a potential intestinal smooth muscle relaxant. Juglone (AJ) was functionalized with dapsone (D) via a solvent-free mechanochemical aza-Michael reaction using silica gel as a mild acid catalyst. The resulting compound (AJ-D) was characterized and evaluated in isolated rat ileum preparations. Pharmacological studies were complemented by molecular docking, density functional theory (DFT) calculations, and in silico ADMET predictions. AJ-D was obtained with complete regioselectivity at the C-3 position and required shorter reaction times than conventional solution-based methods. The compound exhibited significant spasmolytic and antispasmodic effects under basal conditions and against acetylcholine- and KCl-induced contractions. Its relaxant activity was not significantly affected by muscarinic receptor blockade or K+ channel inhibition, whereas verapamil reduced its potency. Calcium reintroduction experiments suggested the involvement of extracellular Ca2+ influx pathways. Docking studies suggested favorable interactions with the CaV1.2 L-type calcium channel, whereas DFT and ADMET analyses indicated suitable electronic and drug-like properties. AJ-D is a promising juglone-derived scaffold with antispasmodic activity, likely associated with the modulation of extracellular calcium influx pathways involved in intestinal smooth muscle contraction.

  • Open Access

    Synthesis of 4-Hydroxyphenylamino-Naphthoquinones as Paracetamol-Inspired Analogs: Chemical, In Silico, and Phenotypic Pharmacological Evaluation

    by Iván M. Quispe-Díaz, Oswaldo Rebaza-Rioja, Sussan Lopez-Mercado, Cinthya Enriquez-Lara, Daniel Asunción-Alvarez, Roberto O. Ybañez-Julca, Elena Mantilla-Rodríguez, Wilfredo O. Gutiérrez-Alvarado, Ricardo Pino-Rios, Jaime A. Valderrama, et al.

    Background/Objectives: Paracetamol is a widely analgesic and antipyretic drug; however, its limited anti-inflammatory efficacy and safety concerns motivate the search for novel non-opioid alternatives. In this study, a series of 4-hydroxyphenylamino-naphthoquinones were designed as paracetamol-inspired analogs and synthesized via a solvent-free, silica-assisted Michael addition, providing a sustainable and efficient synthetic route. Methods: The compounds were evaluated using an integrated strategy combining in silico prediction, density functional theory calculations, molecular docking, ADMET profiling, and in vivo phenotypic pharmacological assays. Results: In vivo evaluation revealed pronounced peripheral antinociceptive activity in the acetic acid-induced writhing model and robust anti-inflammatory effects in carrageenan-induced paw edema, comparable to those of naproxen. These findings suggest a predominantly peripheral mechanism consistent with anti-inflammatory and antinociceptive profiles linked to cyclooxygenase inhibition. A normalization-based multi-criteria analysis integrating peripheral, anti-inflammatory, central, and antipyretic endpoints enabled transparent phenotypic prioritization within the series. Under this framework, compound 7 emerged as the most balanced peripheral–anti-inflammatory candidate, whereas compound 8, evaluated experimentally as a regioisomeric mixture, showed comparatively stronger central antinociceptive activity in the hot plate test. Antipyretic activity in an LPS-induced fever model was limited and not sustained. Conclusions: Overall, these findings indicated that the 4-hydroxyphenylamino-naphthoquinone scaffold emerges as a promising non-opioid platform for peripheral inflammatory pain, supporting further investigation of its pharmacological and mechanistic properties.

  • Open Access

    Exploring the spasmolytic effect of peruvian nogal extract and its metabolite juglone. Potential mechanisms of action: In vitro and in silico studies

    by Roberto O. Ybañez-Julca, Daniel Asunción-Alvarez, Iván M. Quispe-Díaz, Edwin E. Acuña-Tarrillo, Edmundo A. Venegas-Casanova, Rafael Jara-Aguilar, Elena Mantilla-Rodríguez, Cinthya Enríquez, Edison Vásquez-Corales, Marcelo A. Catalán, et al.


  • Open Access

    Chemical Composition, Antioxidant Activities, Antidepressant Effect, and Lipid Peroxidation of Peruvian Blueberry: Molecular Docking Studies on Targets Involved in Oxidative Stress and Depression

    by Iván M. Quispe-Díaz, Roberto O. Ybañez-Julca, Ricardo Pino-Ríos, José D. Quispe-Rodríguez, Daniel Asunción-Alvarez, Elena Mantilla-Rodríguez, Roger A. Rengifo-Penadillos, Edison Vásquez-Corales, Ricardo D. D. G. de Albuquerque, Wilfredo O. Gutiérrez-Alvarado, et al.

    Blueberries (Vaccinium corymbosum L.) are cultivated worldwide and are among the best dietary sources of bioactive compounds with beneficial health effects. This study aimed to investigate the components of Peruvian blueberry using high-performance liquid chromatography coupled to electrospray ionization and quadrupole time-of-flight mass spectrometry (HPLC–ESI–QTOF–MS/MS), identifying 11 compounds. Furthermore, we assessed in vitro the antioxidant activity and in vivo the antidepressant effect using a rat model and protective effect on lipid peroxidation (in the serum, brain, liver, and stomach). We also conducted molecular docking simulations with proteins involved in oxidative stress and depression for the identified compounds. Antioxidant activity was assessed by measuring total phenolic and flavonoid contents, as well as using 1,1-diphenyl-2-picrylhydrazin (DPPH), 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid (ABTS•+), and ferric-reducing antioxidant power (FRAP) assays. Peruvian blueberries demonstrated higher antioxidant activity than Vaccinium corymbosum fruits from Chile, Brazil, the United States, Turkey, Portugal, and China. The results showed that oral administration of Peruvian blueberries (10 and 20 mg/kg) for 28 days significantly (p < 0.001) increased swimming and reduced immobility in the forced swimming test (FST). Additionally, at doses of 40 and 80 mg/kg, oxidative stress was reduced in vivo (p < 0.001) by decreasing lipid peroxidation in brain, liver, stomach, and serum. Molecular docking and absorption, distribution, metabolism, excretion, and toxicity (ADMET) predictions were performed. In the molecular docking studies, quercitrin and 3,5-di-O-caffeoylquinic acid showed the best docking scores for nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, superoxide dismutase, and xanthine oxidase; while 3,5-dicaffeoylquinic acid methyl ester and caffeoyl coumaroylquinic acid had the best docking scores for monoamine oxidase and serotonin receptor 5-HT2. In summary, our results suggest that the antidepressant and protective effects against lipid peroxidation might be related to the antioxidant activity of Peruvian Vaccinium corymbosum L.


  • Open Access

    Antispasmodic Effect of Valeriana pilosa Root Essential Oil and Potential Mechanisms of Action: Ex Vivo and In Silico Studies

    by Roberto O. Ybañez-Julca, Ricardo Pino-Ríos, Iván M. Quispe-Díaz, Daniel Asunción-Alvarez, Edwin E. Acuña-Tarrillo, Elena Mantilla-Rodríguez, Patricia Minchan-Herrera, Marcelo A. Catalán, Liz Zevallos-Escobar, Edison Vásquez-Corales, et al.

    Infusions of Valeriana pilosa are commonly used in Peruvian folk medicine for treating gastrointestinal disorders. This study aimed to investigate the spasmolytic and antispasmodic effects of Valeriana pilosa essential oil (VPEO) on rat ileum. The basal tone of ileal sections decreased in response to accumulative concentrations of VPEO. Moreover, ileal sections precontracted with acetylcholine (ACh), potassium chloride (KCl), or barium chloride (BaCl2) were relaxed in response to VPEO by a mechanism that depended on atropine, hyoscine butylbromide, solifenacin, and verapamil, but not glibenclamide. The results showed that VPEO produced a relaxant effect by inhibiting muscarinic receptors and blocking calcium channels, with no apparent effect on the opening of potassium channels. In addition, molecular docking was employed to evaluate VPEO constituents that could inhibit intestinal contractile activity. The study showed that α-cubebene, β-patchoulene, β-bourbonene, β-caryophyllene, α-guaiene, γ-muurolene, valencene, eremophyllene, and δ-cadinene displayed the highest docking scores on muscarinic acetylcholine receptors and voltage-gated calcium channels, which may antagonize M2 and/or M3 muscarinic acetylcholine receptors and block voltage-gated calcium channels. In summary, VPEO has both spasmolytic and antispasmodic effects. It may block muscarinic receptors and calcium channels, thus providing a scientific basis for its traditional use for gastrointestinal disorders.